Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zometa for bone loss in premenopausal HR-negative breast cancer
NCT00333229Phase 4Terminated
- Sponsor
- Novartis
- Start
- Mar 2006
- Primary completion
- Dec 2013
- Countries
- 1
01
Overview
A Phase 4 trial of zoledronic acid in osteoporosis, sponsored by Novartis. Started Mar 2006; status: terminated.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00333229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00333229.